ARCHIVES

Komen Under Pressure: Charity Faces Money Woes, Attacks from Right

This article is from The Cancer Letter archive.

Vol. 38 No. 40 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008

In Brief: Gusberg Heads ACS, With Scanlon As President Elect; MDA honors Holland, D’Angio, Landing

November 16, 1979

Panel Resumes Deliberations

January 4, 1980

Research teams link response to Iressa to mutations in EGF receptor.

April 30, 2004